Results for tag: "Interstitial Cystitis Drug"

Interstitial Cystitis (IC) is a chronic urological disorder characterized by bladder pain and pressure, urinary frequency, and urgency. It is estimated to affect up to 8 million people in the United States alone. Treatment for IC is typically focused on symptom relief and can include medications, dietary changes, physical therapy, and bladder instillations. Drugs used to treat IC include anticholinergics, anti-inflammatory agents, and analgesics. Anticholinergics are used to reduce bladder spasms and urinary frequency, while anti-inflammatory agents are used to reduce inflammation and pain. Analgesics are used to reduce pain and discomfort. Other drugs used to treat IC include tricyclic antidepressants, pentosan polysulfate sodium, and amitriptyline. The Interstitial Cystitis Drug market is a rapidly growing segment of the Urological Disorders Drugs market. It is estimated to reach a value of over $1 billion by 2027, driven by the increasing prevalence of IC and the growing demand for effective treatments. Some of the major companies in the Interstitial Cystitis Drug market include Pfizer, Inc., Allergan, Inc., Astellas Pharma, Inc., Endo Pharmaceuticals, Inc., and Mylan N.V. Show Less Read more